TRCT
MRAI

Tower Research Capital (TRC)’s Marpai, Inc. Class A Common Stock MRAI Stock Holding History

Tower Research Capital (TRC)’s Portfolio MRAI Stock Details MRAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,724
Closed -$6.65K – 6197
2024
Q1 		$6.65K Buy
2,724
+434
+19% +$692 ﹤0.01% 4338
2023
Q4 		$4.01K Sell
2,290
-616
-21% -$715 ﹤0.01% 5007
2023
Q3 		$1.92K Sell
2,906
-2,794
-49% -$3.51K ﹤0.01% 5240
2023
Q2 		$9.75K Buy
5,700
+3,435
+152% +$9.87K ﹤0.01% 4222
2023
Q1 		$9K Sell
2,265
-447
-16% -$1.63K ﹤0.01% 4595
2022
Q4 		$8K Buy
2,712
+1,170
+76% +$4.4K ﹤0.01% 4510
2022
Q3 		$6K Sell
1,542
-1,437
-48% -$5.5K ﹤0.01% 5098
2022
Q2 		$12K Buy
2,979
+2,916
+4,629% +$15.5K ﹤0.01% 4333
2022
Q1 		$0 Sell
63
-67
-52% -$611 ﹤0.01% 6867
2021
Q4 		$2K Buy
+130
New +$2.4K ﹤0.01% 5723

Tower Research Capital (TRC)'s MRAI Position: Q2 2024 in Review

Tower Research Capital (TRC) sold out of Marpai, Inc. Class A Common Stock (MRAI) in Q2 2024, closing a stake of 2,724 shares — an estimated $6.65K sold.

Tower Research Capital (TRC) first reported a position in MRAI in Q4 2021 and held it in 10 quarters. The position peaked at $12K in Q2 2022. 0 funds tracked by Wall St. Rank hold MRAI as of Q2 2024.

  • Tower Research Capital (TRC) reported no remaining Marpai, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 2,724 Marpai, Inc. Class A Common Stock shares in Q2 2024, an estimated $6.65K.
  • Tower Research Capital (TRC) first reported a position in Marpai, Inc. Class A Common Stock in Q4 2021 and held it in 10 quarters.
  • Tower Research Capital (TRC)'s Marpai, Inc. Class A Common Stock position peaked at $12K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Marpai, Inc. Class A Common Stock as of Q2 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.